Succeeded in production in one month with support from Samsung…靑 “Vaccine injection, the myth of K-prevention”

Input 2021.02.18 15:52

靑 “It is difficult for countries around the world to secure vaccine syringes”
Park Young-sun, domestic vaccine syringe received approval from the US FDA
“Japan discards the vaccine because it cannot secure this syringe”… Inoculation from the 17th

President Moon Jae-in visited the production site of the LDS (Low Dead Space) vaccine syringe for corona 19 vaccination on the 18th. A typical syringe can be inoculated 5 times with a single vaccine bottle, but with this syringe, you can inoculate 6 times. The Blue House said about a company that produces LDS vaccine syringes, “I am writing the myth of K-quarantine after masks and diagnostic reagents.”

President Moon visited Poonglim Pharmatech in the Gunsan Free Trade Zone in Gunsan City, Jeollabuk-do this afternoon. The event was attended by executives of companies producing LDS vaccine syringes such as Poonglim Pharmatech, Shin-A Yanghaeng, and Doowon Meditech, as well as officials from the Samsung Electronics Smart Factory Support Center, which supports the efficient vaccine syringe production process.

The Blue House said about President Moon’s visit to the vaccine syringe production site, “It is difficult because countries around the world have not been able to secure LDS vaccine syringes,” and said, “In the case of Korea, we are supplying sufficient quantities to Korea.”

Shin-A Yanghaeng developed the first LDS syringe in Korea in 1995. Doowon Meditech preemptively expanded its LDS vaccine production capacity on the occasion that an employee was classified as a corona symptoms and suffered a workplace shutdown crisis at the beginning of last year. Poonglim Pharmatech imports and sells medical devices, and is engaged in the localization business of medical devices, and succeeded in producing LDS vaccine syringes due to the corona crisis. Poonglim Pharmatech completed the production of LDS vaccine syringe prototypes in one month with the support of Samsung Electronics for the government’s “large, small and medium-sized smart factory construction project.

Regarding the event, Se-eun Lim, a deputy spokesman at the Blue House, said, “The minimum residual vaccine syringe of Poonglim Pharmatech that President Moon visits was officially approved by the US Food and Drug Administration (FDA) on the 17th,” he said. “In the US, Europe, the Middle East, and Southeast Asia, “The purchase request is inundated.” He said of the company attending this event, “I am writing the myth of K-prevention following masks and diagnostic reagents.”

Vaccination syringes produced in Korea have become a hot topic due to the recent corona vaccination situation in Japan. The Japanese government was unable to secure the syringe, so about 12 million of the 72 million Pfizer vaccines contracted for supply in Japan must be discarded. Japan started vaccination produced by Pfizer from the previous day (17th).

Park Young-seon, former Minister of SMEs and Startups, who ran for the Seoul Mayor’s by-election, said in a Facebook post posted on the previous day when Poonglim Pharmatech’s vaccine syringes were approved by the US FDA, “I came out with the final work as the Minister of SMEs, and Japan secured this syringe. It is said that the vaccine was discarded because it was not possible,” he wrote.

Corona vaccination is being performed in more than 70 countries around the world, and corona vaccination is being conducted for the first time on the 26th in Korea. The AstraZeneca vaccine produced at the SK Bioscience plant in Andong, Gyeongsangbuk-do will be supplied to the Korean government for the first time on the 24th. 117,000 doses of Pfizer vaccine to be introduced through the’COVAX Facility’, an international project for joint vaccine purchase and distribution, will come in from late February to early March. The amount of vaccines that the Korean government has signed with Pfizer will come in late March and begin vaccination in early April.